Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SGML | USAS |
|---|---|---|
| Price | $9.86 | $4.17 |
| Change today | ▲ 1.54% | ▼ 6.71% |
| Market cap | $1.11B | $1.41B |
| Return, 3 months | -16.6% | -6.5% |
| Return, year to date | -25.2% | -18.4% |
| Return, 1 year | +40.3% | -3.5% |
| P/E (TTM) | -41.1 | -23.2 |
| P/B | 13.5 | 4.8 |
| P/E percentile vs own 5y | 51st | 7th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +223.9% | +72.1% |
| Net profit growth (YoY) | +86.0% | +66.9% |
| Gross margin | 49.1% | 38.8% |
| Operating margin | 19.6% | 15.5% |
| Net margin | -19.3% | -26.3% |
| Return on equity | -31.6% | – |
| Analyst target vs. price | +6.5% | +112.2% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 48 | 36 |
| 30-day volatility | 89.0% | 67.5% |
| Max drawdown, 1 year | -64.8% | -63.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
